These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27653941)

  • 1. Ciprofloxacin Exposure Leading to Fatal Hepatotoxicity: An Unusual Correlation.
    Unger C; Al-Jashaami LS
    Am J Case Rep; 2016 Sep; 17():676-681. PubMed ID: 27653941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin-induced Hepatotoxicity in a Healthy Young Adult.
    Qutrio Baloch Z; Raza MA; Abbas SA; Bukhari S
    Cureus; 2017 Feb; 9(2):e1016. PubMed ID: 28348936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Cholestatic Liver Injury Due to Ciprofloxacin in a Young Healthy Adult.
    Ahmad W; Waqar M; Hadi MH; Muhammad AS; Iqbal N
    Cureus; 2021 Feb; 13(2):e13340. PubMed ID: 33747648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.
    Carrascosa MF; Lucena MI; Andrade RJ; Caviedes JR; Lavín AC; Mones JC; Rivero AP; Serrano VB
    Clin Ther; 2009 May; 31(5):1014-9. PubMed ID: 19539102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible ciprofloxacin-induced acute cholestatic jaundice.
    Sherman O; Beizer JL
    Ann Pharmacother; 1994 Oct; 28(10):1162-4. PubMed ID: 7841570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of fosinopril-induced severe cholestatic jaundice with plasma exchange.
    Chou JW; Yu CJ; Chuang PH; Lai HC; Hsu CH; Cheng KS; Peng CY; Chiang IP
    Ann Pharmacother; 2008 Dec; 42(12):1887-92. PubMed ID: 19017832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobramycin-induced hepatotoxicity.
    Nisly SA; Ray SM; Moye RA
    Ann Pharmacother; 2007 Dec; 41(12):2061-5. PubMed ID: 17956959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Cholestatic Liver Injury From Hydralazine Intake.
    Harati H; Rahmani M; Taghizadeh S
    Am J Ther; 2016; 23(5):e1211-4. PubMed ID: 26291593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suspected ciprofloxacin-induced hepatotoxicity.
    Villeneuve JP; Davies C; Côté J
    Ann Pharmacother; 1995 Mar; 29(3):257-9. PubMed ID: 7606070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast induced acute hepatocellular liver injury.
    Harugeri A; Parthasarathi G; Sharma J; D'Souza GA; Ramesh M
    J Postgrad Med; 2009; 55(2):141-2. PubMed ID: 19550064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
    Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
    Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydralazine-induced cholestatic hepatitis.
    Hassan A; Hammad R; Cucco R; Niranjan S
    Am J Ther; 2009; 16(4):371-3. PubMed ID: 19092641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A challenge for diagnosing acute liver injury with concomitant/sequential exposure to multiple drugs: can causality assessment scales be utilized to identify the offending drug?
    Lim R; Choudry H; Conner K; Karnsakul W
    Case Rep Pediatr; 2014; 2014():156389. PubMed ID: 25506455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature.
    Radovanovic M; Dushenkovska T; Cvorovic I; Radovanovic N; Ramasamy V; Milosavljevic K; Surla J; Jecmenica M; Radulovic M; Milovanovic T; Dumic I
    Am J Case Rep; 2018 Sep; 19():1152-1161. PubMed ID: 30266895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible gatifloxacin-induced fulminant hepatic failure.
    Coleman CI; Spencer JV; Chung JO; Reddy P
    Ann Pharmacother; 2002; 36(7-8):1162-7. PubMed ID: 12086547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature.
    Gharia B; Seegobin K; Maharaj S; Marji N; Deutch A; Zuberi L
    Oxf Med Case Reports; 2017 Nov; 2017(11):omx074. PubMed ID: 29230302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
    Paredes AH; Lewis JH
    Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
    Danan G; Teschke R
    Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albendazole-induced granulomatous hepatitis: a case report.
    Marin Zuluaga JI; Marin Castro AE; Perez Cadavid JC; Restrepo Gutierrez JC
    J Med Case Rep; 2013 Jul; 7():201. PubMed ID: 23889970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible amlodipine-induced hepatotoxicity after stem cell transplant.
    Hammerstrom AE
    Ann Pharmacother; 2015 Jan; 49(1):135-9. PubMed ID: 25239629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.